Physician profile
Anna Kogan
NPI 1518103290
$986.88
in general payments reported to CMS, 2019-2025
10 companies · $93.95 in 2025
The $93.95 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $20.28 · 2021: $51.82 · 2022: $79.57 · 2023: $222 · 2024: $271 · 2025: $93.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $304.30 | 2019-2024 | Cleviprex, Kengreal |
| Abbvie INC. | $195.42 | 2023-2025 | |
| Mml US, INC. | $127.21 | 2023 | Reactiv8 |
| Comsort, INC | $100.00 | 2019 | |
| Lilly USA, LLC | $78.85 | 2024 | Kisunla, Emgality |
| Eisai INC. | $59.29 | 2022 | |
| Lundbeck LLC | $46.34 | 2025 | Vyepti |
| Baudax Bio INC. | $35.55 | 2021 | |
| Merck Sharp & Dohme LLC | $20.28 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $19.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.